beth israel deaconess medical center a harvard medical school teaching hospital

Find a Doctor

Request an Appointment

left banner
right banner
Smaller Larger

Barbara Kahn Named Vice Chair of Research Strategy

Position in BIDMC's Department of Medicine

BOSTON - Barbara Kahn, MD, an internationally renowned scientist whose investigations are helping to illuminate the molecular bases of obesity and Type 2 diabetes, has been named Vice Chair of Research Strategy in the  Department of Medicine at Beth Israel Deaconess Medical Center (BIDMC).

"Dr. Kahn's more than 25 years of research has provided us with a richer understanding of metabolic disease," says Mark Zeidel, MD, Chairman of the Department of Medicine at BIDMC. "In her new position, Barbara's leadership and vision will be invaluable in shaping our department's research mission, and in developing new collaborations and resources with surrounding institutes and programs, endeavors that will further enrich BIDMC's overall research program."

The George R. Minot Professor of Medicine at Harvard Medical School, Kahn joined the faculty of BIDMC in 1986 and has served as chief of BIDMC's Division of Endocrinology, Diabetes and Metabolism for the past 11 years, following 10 years as Chief of the Diabetes Unit. She is a member of the Institute of Medicine of the National Academy of Sciences and was the 2010-2011 Edward, Frances, and Shirley B. Daniels Fellow in Medical Sciences at the Radcliffe Institute for Advanced Study.

Kahn received her MD from Stanford University and holds an MS in Health and Medical Sciences from the University of California, Berkeley. After completing training in internal medicine at the UC Davis Medical Center, Kahn began her career in molecular research as a Fellow at the National Institutes of Health (NIH).

An internationally recognized scientist in the studies of obesity and diabetes, Kahn's lab investigates the molecular mechanisms underlying these conditions, including the regulation of insulin action, food intake, and energy balance.

She has received numerous awards including the Outstanding Scientific Achievement Award from the American Diabetes Association; the H. C. Jacobaeus Prize from the Novo Nordisk Foundation and the Karolinska Instituet; the Charles H. Best Lectureship and Award from the University of Toronto; and the Gerald D. Aurbach Award Lecture from the Endocrine Society. Kahn is also a fellow of the American Association for the Advancement of Science and holds a MERIT Award from the National Institutes of Health .

Kahn served on the National Board of Directors of the American Diabetes Association, where she chaired several national ADA committees. She also served on both the Diabetes and Obesity Committees of the American Heart Association, and has been a consultant to the NIH National Diabetes Advisory Board and the NHLBI/NIH Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease. She has mentored dozens of trainees who have gone on to be outstanding independent scientists.

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and ranks third in National Institutes of Health funding among independent hospitals nationwide. BIDMC is a clinical partner of the Joslin Diabetes Center and a research partner of the Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit